How Varithena Treatment Improves Leg Pain and Circulation
It frequently begins slowly, with heaviness in the legs, minor swelling by evening, or painful discomfort after standing for too long, and many individuals ignore these sensations as weariness; however, for millions of Americans, these are early symptoms of chronic venous insufficiency (CVI).
According to the Society for Vascular Surgery and the American Venous Forum, more than 25 million adults in the United States have varicose veins, and approximately 6–7 million suffer from advanced chronic venous disease. Epidemiological studies estimate that nearly 23% of U.S. adults are affected, with women more commonly impacted.
Varicose veins are not merely cosmetic; actually, they result from malfunctioning venous valves that allow blood to flow backwards and pool in the legs. Over time, this venous reflux increases pressure in the lower extremities, leading to pain, swelling, skin changes, and, in severe cases, venous ulcers.
What Is Varithena?
Varithena is an FDA-approved injectable microfoam (1% polidocanol) indicated for treating incompetent great saphenous veins and associated tributaries, and it is a minimally invasive, ultrasound-guided procedure performed in an outpatient setting.
During therapy, a vein expert injects the unique foam directly into the affected vein using duplex ultrasound guidance, and the foam displaces blood, forcing the vein walls to collapse and close off. Once closed, blood spontaneously reroutes through healthier veins, improving overall circulation.
Unlike traditional vein stripping surgery, Varithena treatment does not require major incisions and allows patients to return to regular activities quickly.
Clinical Evidence Supporting Symptom Relief
Precision is essential in medical discussions. Varithena’s efficacy was demonstrated in randomised, placebo-controlled Phase III trials published in Phlebology (Todd et al., 2014), which supported its FDA approval.
In these studies:
Patients had statistically significant decreases in heaviness, hurting, swelling, throbbing, and itching compared to placebo (p < 0.001).
Improvements were measured using validated methods, such as the VEINES-QOL/Sym score.
After three months, duplex ultrasonography examinations revealed vein closure rates ranging from 83% to 94%, depending on vein characteristics.
Patients report lighter legs, reduced ankle edema, and greater comfort during daily activities.
How Circulation Improves
Because of gravity, blood can accumulate in the lower legs in CVI owing to malfunctioning valves. Inflammation and pain are brought on by this pooling, which raises venous pressure.
By blocking the refluxing vein, Varithena vein treatment stops blood flow in the opposite direction. Blood flow is rerouted to healthy channels, and venous pressure drops when the malfunctioning vein is removed from circulation. Decreased venous hypertension slows the progression of skin abnormalities associated with severe illness, as well as discomfort and edema.
Final Thoughts
Accurate vein mapping and an appropriate ultrasound-guided injection technique are essential for successful results. Patients should look for interventional radiologists with experience in foam sclerotherapy, board-certified vascular surgeons, or vein specialists.
By treating the symptoms and underlying cause of chronic venous insufficiency, Varithena offers a minimally invasive, evidence-based solution for leg pain relief and venous circulation restoration. To achieve perfect form implantation and detailed mapping of damaged veins, a certified Varithena specialist at Advanced Cardiovascular Center employs duplex ultrasonography.

Comments
Post a Comment